|The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes|
M Polymenidou, R Moos, M Scott, C Sigurdson, Y Shi, B Yajima, ...
PloS one 3 (12), e3872, 2008
|Biomarkers of endocannabinoid system activation in severe obesity|
JC Sipe, TM Scott, S Murray, O Harismendy, GM Simon, BF Cravatt, ...
PloS one 5 (1), e8792, 2010
|A global benchmark study using affinity-based biosensors|
RL Rich, GA Papalia, PJ Flynn, J Furneisen, J Quinn, JS Klein, ...
Analytical biochemistry 386 (2), 194-216, 2009
|Critical evaluation of mass spectrometric measurement of dissociation constants: accuracy and cross-validation against surface plasmon resonance and circular dichroism for the …|
S Mathur, M Badertscher, M Scott, R Zenobi
Phys. Chem. Chem. Phys. 9 (47), 6187-6198, 2007
|Differential antiproliferative mechanisms of novel derivative of benzimidazo [1, 2-α] quinoline in colon cancer cells depending on their p53 status|
M Sedic, M Poznic, P Gehrig, M Scott, R Schlapbach, M Hranjec, ...
Molecular cancer therapeutics 7 (7), 2121, 2008
|The proteome of mouse brain microvessel membranes and basal lamina|
HB Chun, M Scott, S Niessen, H Hoover, A Baird, J Yates, BE Torbett, ...
Journal of Cerebral Blood Flow & Metabolism, 2011
|Characterization of antibody–antigen interactions: Comparison between surface plasmon resonance measurements and high-mass matrix-assisted laser desorption/ionization mass …|
C Bich, M Scott, A Panagiotidis, RJ Wenzel, A Nazabal, R Zenobi
Analytical biochemistry 375 (1), 35-45, 2008
|Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level|
O Harismendy, V Bansal, G Bhatia, M Nakano, M Scott, X Wang, C Dib, ...
Genome Biology 11 (11), R118, 2010
|An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease|
S Kraljevic Pavelic, M Sedic, K Hock, S Vucinic, D Jurisic, P Gehrig, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
|Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?|
S Kraljevic, M Sedic, M Scott, P Gehrig, R Schlapbach, K Pavelic
Cancer treatment reviews 32 (8), 619-629, 2006
|MnSOD marks cord blood late outgrowth endothelial cells and accompanies robust resistance to oxidative stress|
H Cai, P Gehrig, TM Scott, R Zimmermann, R Schlapbach, AH Zisch
Biochemical and biophysical research communications 350 (2), 364-369, 2006
|Assessment of the Red Cell Proteome of Young Patients with Unexplained Hemolytic Anemia by Two-Dimensional Differential In-Gel Electrophoresis (DIGE)|
K von Löhneysen, TM Scott, K Soldau, X Xu, JS Friedman
PLoS ONE 7 (4), e34237, 2012
|Nuclear magnetic resonance study of the kinetics of the penicillamine/bis (penicillamine) selenide symmetrical exchange reaction|
DL Rabenstein, TM Scott, W Guo
The Journal of Organic Chemistry 56 (13), 4176-4181, 1991
|An inhibitor of the pleckstrin homology domain of CNK1 selectively blocks the growth of mutant KRAS cells and tumors|
M Indarte, R Puentes, M Maruggi, NT Ihle, G Grandjean, M Scott, Z Ahmed, ...
Cancer research 79 (12), 3100-3111, 2019
|Differential display and protein quantification|
E Brunner, B Gerrits, M Scott, B Roschitzki
Plant Systems Biology, 115-140, 2007
|Metabolome Changes during In Vivo Red Cell Aging Reveal Disruption of Key Metabolic Pathways|
N Jamshidi, X Xu, K von Löhneysen, K Soldau, RP Mohney, ED Karoly, ...
Iscience 23 (10), 101630, 2020
|Targeting the KRAS signaling naocluster protein CNKSR1 provides antitumor activity against mutant KRAS xenografts|
G Triana-Balzer, M Indarte, M Scott, G Powis, DL Kirkpatrick
Cancer Research 74 (19 Supplement), 2671-2671, 2014
|Proteomic analyses of src+/+ and src−/− mouse brain microvessels reveals insights into the regulation of the blood brain barrier integrity|
P Minder, M Scott, JJ Moresco, A Baird, JR Yates 3rd, BP Eliceiri, ...
The FASEB Journal 30, lb455-lb455, 2016
|Abstract C131:‘KRAS addiction’an artifact of 2D culture? Inhibitors of the mut-KRAS NSCLC 3D growth|
DL Kirkpatrick, R Delaney, G Grandjean, A Madrigal, M Indarte, M Scott, ...
Molecular Cancer Therapeutics 14 (12 Supplement 2), C131-C131, 2015
|Refinement of inhibitors of the KRAS-signaling naocluster protein, CNKSR1, that block oncogenic KRAS signaling and growth|
DL Kirkpatrick, M Indarte, M Scott, A Madrigal, G Grandjean, G Powis
Cancer Research 75 (15 Supplement), 2583-2583, 2015